Home›Grapefruit Juice›Grapefruit Juice + Butalbital Acetaminophen Caffeine And Codeine Phosphate

Does Grapefruit Juice Interact with Butalbital Acetaminophen Caffeine And Codeine Phosphate?

CDI records a major classification for Grapefruit Juice and Butalbital Acetaminophen Caffeine And Codeine Phosphate. The stored summary is: CYP3A4 inhibitor may increase codeine plasma concentrations and morphine levels, potentially causing fatal respiratory depression, particularly when added after stable dosing. The mechanism involves inhibition of cyp3a4, increasing codeine metabolism to morphine via cyp2d6. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Butalbital Acetaminophen Caffeine And Codeine Phosphate Class
Barbiturate
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

Inhibition of CYP3A4, increasing codeine metabolism to morphine via CYP2D6

What To Tell Your Doctor or Pharmacist

If you are taking Grapefruit Juice and your doctor is considering prescribing Butalbital Acetaminophen Caffeine And Codeine Phosphate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Grapefruit Juice+💊 Butalbital Acetaminophen Caffeine And Codeine Phosphate(Fioricet With Codeine)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Barbiturate
Source
NLP:butalbital, acetaminophen, caffeine and codeine phosphate

What this means in plain English

CYP3A4 inhibitor may increase codeine plasma concentrations and morphine levels, potentially causing fatal respiratory depression, particularly when added after stable dosing.

About Grapefruit Juice and Butalbital Acetaminophen Caffeine And Codeine Phosphate

Butalbital Acetaminophen Caffeine And Codeine Phosphate is a Barbiturate. Butalbital Acetaminophen Caffeine And Codeine Phosphate additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:butalbital, acetaminophen, caffeine and codeine phosphate

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Grapefruit Juice and Butalbital Acetaminophen Caffeine And Codeine Phosphate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations